About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 39 record(s)
Req # A-2021-24151
All data source files used to produce the CompassRx 7th Edition Annual Public Drug Plan Expenditure Report, 2019/20, published November 2021 and available here:https://www.canada.ca/en/patented-medicine-prices-review/services/npduis/analytical-studies/compassrx-7th-edition.html and here:https://www.canada.ca/content/dam/pmprb-cepmb/documents/npduis/analytical-studies/compassrx-7th-edition/NPDUIS-CompassRx7th-2019-2020_en.pdf.Organization: Patented Medicine Prices Review Board Canada
January 2022
Req # A-2021-24939
Copies of the preparation documents, meeting summaries and emails related to the weekly meetings between Douglas Clark and Mitchell Levine from May 1, 2021 to December 20, 2021.Organization: Patented Medicine Prices Review Board Canada
January 2022
Req # A-2021-24944
Copies of all preparation documents, meeting summaries, meeting recordings (if applicable), chats from the meeting and emails related to the ATIP update meetings involving Douglas Clark from June 2-9, 2021.Organization: Patented Medicine Prices Review Board Canada
January 2022
Req # A-2021-24949
Copies of all records related to the board meeting regarding the consultation results update on September 1, 2021 as referenced in Douglas Clark's calendar.Organization: Patented Medicine Prices Review Board Canada
January 2022
Req # A-2021-24950
Copies of all communication plans, strategies or similar documents prepared by PMPRB staff between May 1, 2021 and December 20, 2021.Organization: Patented Medicine Prices Review Board Canada
January 2022
Req # A-2021-002
All correspondence, emails, notes and reports pertaining to the CAN/HRSO-500.02-2021, Service Dogs, Therapy Dogs, Guide Dogs and all types of Animal-Assisted Services (AAS). The timeframe for this request is from April 1st, 2018 to April 9th, 2021.Organization: Standards Council of Canada
January 2022
Req # A-2021-07238
Copies of all information, data, document, or correspondence concerning the PMPRB's classification of the following drug products: NOVORAPID and FIASP, each a product of NOVO NORDISK CANADA INC, a corporation located at 101-2476 Argentia Road, Mississauga, Ontario, Canada L5N 6M1, including but not limited to classifications based on drug product line extensions, similar chemical entities, comparable dosages, or a reasonable relationship between the two drugs, as well as any other analysis, comments, or information related to the classification of these two drugs.Organization: Patented Medicine Prices Review Board Canada
May 2021
Req # A-2021-07885
Copies of all briefing notes provided to the Deputy Minister regarding the implementation of the new PMPRB guidelines on July 1, 2021 from January 1, 2021 to April 28, 2021.Organization: Patented Medicine Prices Review Board Canada
May 2021
Req # A-2021-07888
Copies of all briefing notes provided to the Deputy Minister regarding the possible delay in the implementation of the new PMPRB guidelines from January 1, 2021 to April 28, 2021.Organization: Patented Medicine Prices Review Board Canada
May 2021
Req # A-2021-07890
Copies of all emails sent/received from Douglas Clark, Tanya Potashnik, Mitchell Levine and Isabel Jaen Raasch discussing the possible delaying in the implementation of the new PMPRB guidelines from January 1, 2021 to April 28, 2021.Organization: Patented Medicine Prices Review Board Canada
May 2021